The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Open accessAbstract
Background: Antimicrobial-resistant infections are commonly encountered in US hospitals and result in significant morbidity and mortality. This guidance document provides recommendations for the treatment of infections caused by extended-spectrum β-lactamase–producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Methods: A panel of 6 infectious diseases specialists with expertise in managing antimicrobial-resistant infections formulated common questions regarding the treatment of ESBL-E, CRE, and DTR-P. aeruginosa infections. Based on review of the published literature and clinical experience, the panel provide recommendations and associated rationale for each recommendation. Because of significant differences in the molecular epidemiology of resistance and the availability of specific anti-infective agents globally, this document focuses on treatment of antimicrobial-resistant infections in the United States. Results: Approaches to empiric treatment selection, duration of therapy, and other management considerations are briefly discussed. The majority of guidance focuses on preferred and alternative treatment recommendations for antimicrobial-resistant infections, assuming that the causative organism has been identified and antibiotic susceptibility testing results are known. Treatment recommendations apply to both adults and children. Conclusions: The field of antimicrobial resistance is dynamic and rapidly evolving, and the treatment of antimicrobial-resistant infections will continue to challenge clinicians. This guidance document is current as of 17 September 2020. Updates to this guidance document will occur periodically as new data emerge. Furthermore, the panel will expand recommendations to include other problematic gram-negative pathogens in future versions. The most current version of the guidance including the date of publication can be found at www.idsociety.org/practice-guideline/amr-guidance/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
The global epidemiology of carbapenemase-producing Enterobacteriaceae
van Duin, D., & Doi, Y. (2017) · Virulence · doi:10.1080/21505594.2016.1222343 · Cited by 1,004
Self-citationTsuji, B. T., Pogue, J. M., Zavascki, A. P., Paul, M., Daikos, G. L., Forrest, A., Giacobbe, D. R., Viscoli, C., Giamarellou, H., Karaiskos, I., et al. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2209 · Cited by 949
Epidemiology of β-Lactamase-Producing Pathogens
Bush, K., & Bradford, P. A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-19 · Cited by 938
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Self-citationPharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
Agwuh, K. N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl224 · Cited by 806
Harris, P. N. A., Tambyah, P. A., Lye, D. C., Mo, Y., Lee, T. H., Yilmaz, M., Alenazi, T. H., Arabi, Y., Falcone, M., Bassetti, M., et al. (2018) · JAMA · doi:10.1001/jama.2018.12163 · Cited by 774
van Duin, D., Lok, J. J., Earley, M., Cober, E., Richter, S. S., Perez, F., Salata, R. A., Kalayjian, R. C., Watkins, R. R., Doi, Y., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix783 · Cited by 655
Self-citationKadri, S. S., Adjemian, J., Lai, Y. L., Spaulding, A. B., Ricotta, E., Prevots, D. R., Palmore, T. N., Rhee, C., Klompas, M., Dekker, J. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy378 · Cited by 605
Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012-2017.
Jernigan, J. A., Hatfield, K. M., Wolford, H., Nelson, R. E., Olubajo, B., Reddy, S. C., McCarthy, N., Paul, P., McDonald, L. C., Kallen, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1914433 · Cited by 577
Shields, R. K., Nguyen, M. H., Chen, L., Press, E. G., Potoski, B. A., Marini, R. V., Doi, Y., Kreiswirth, B. N., & Clancy, C. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00883-17 · Cited by 495
Self-citationShields, R. K., Chen, L., Cheng, S., Chavda, K. D., Press, E. G., Snyder, A., Pandey, R., Doi, Y., Kreiswirth, B. N., Nguyen, M. H., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02097-16 · Cited by 484
Self-citationWunderink, R. G., Giamarellos-Bourboulis, E. J., Rahav, G., Mathers, A. J., Bassetti, M., Vazquez, J., Cornely, O. A., Solomkin, J., Bhowmick, T., Bishara, J., et al. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0214-1 · Cited by 461
Self-citationTorres, A., Zhong, N., Pachl, J., Timsit, J.-F., Kollef, M., Chen, Z., Song, J., Taylor, D., Laud, P. J., Stone, G. G., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30747-8 · Cited by 441
Sandri, A. M., Landersdorfer, C. B., Jacob, J., Boniatti, M. M., Dalarosa, M. G., Falci, D. R., Behle, T. F., Bordinhão, R. C., Wang, J., Forrest, A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit334 · Cited by 430
Motsch, J., Murta de Oliveira, C., Stus, V., Köksal, I., Lyulko, O., Boucher, H. W., Kaye, K. S., File, T. M., Brown, M. L., Khan, I., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz530 · Cited by 422
Solomkin, J., Hershberger, E., Miller, B., Popejoy, M., Friedland, I., Steenbergen, J., Yoon, M., Collins, S., Yuan, G., Barie, P. S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ097 · Cited by 420
Portsmouth, S., van Veenhuyzen, D., Echols, R., Machida, M., Ferreira, J. C. A., Ariyasu, M., Tenke, P., & Nagata, T. D. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30554-1 · Cited by 420
Carmeli, Y., Armstrong, J., Laud, P. J., Newell, P., Stone, G., Wardman, A., & Gasink, L. B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30004-4 · Cited by 417
Tamma, P. D., Goodman, K. E., Harris, A. D., Tekle, T., Roberts, A., Taiwo, A., & Simner, P. J. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw741 · Cited by 402
Self-citationMazuski, J. E., Gasink, L. B., Armstrong, J., Broadhurst, H., Stone, G. G., Rank, D., Llorens, L., Newell, P., & Pachl, J. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw133 · Cited by 393
Wagenlehner, F. M., Umeh, O., Steenbergen, J., Yuan, G., & Darouiche, R. O. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62220-0 · Cited by 388
Babinchak, T., Ellis‐Grosse, E., Dartois, N., Rose, G. M., Loh, E., & Groups, T. 3. A. 3. S. (2005) · Clinical Infectious Diseases · doi:10.1086/431676 · Cited by 381
Zhanel, G. G., Lawrence, C. K., Adam, H., Schweizer, F., Zelenitsky, S., Zhanel, M., Lagacé-Wiens, P. R. S., Walkty, A., Denisuik, A., Golden, A., et al. (2018) · Drugs · doi:10.1007/s40265-017-0851-9 · Cited by 377
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013
Guh, A. Y., Bulens, S. N., Mu, Y., Jacob, J. T., Reno, J., Scott, J., Wilson, L. E., Vaeth, E., Lynfield, R., Shaw, K. M., et al. (2015) · JAMA · doi:10.1001/jama.2015.12480 · Cited by 369
Wagenlehner, F. M., Sobel, J. D., Newell, P., Armstrong, J., Huang, X., Stone, G. G., Yates, K., & Gasink, L. B. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw378 · Cited by 362
Tumbarello, M., Trecarichi, E. M., Corona, A., De Rosa, F. G., Bassetti, M., Mussini, C., Menichetti, F., Viscoli, C., Campoli, C., Venditti, M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy492 · Cited by 354
Kollef, M. H., Nováček, M., Kivistik, Ü., Réa-Neto, Á., Shime, N., Martin-Loeches, I., Timsit, J.-F., Wunderink, R. G., Bruno, C. J., Huntington, J. A., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30403-7 · Cited by 345
van Duin, D., Arias, C. A., Komarow, L., Chen, L., Hanson, B. M., Weston, G., Cober, E., Garner, O. B., Jacob, J. T., Satlin, M. J., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30755-8 · Cited by 337
Self-citationKaye, K. S., Bhowmick, T., Metallidis, S., Bleasdale, S. C., Sagan, O. S., Stus, V., Vazquez, J., Zaitsev, V., Bidair, M., Chorvat, E., et al. (2018) · JAMA · doi:10.1001/jama.2018.0438 · Cited by 314
Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates
Tamma, P. D., & Simner, P. J. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01140-18 · Cited by 293
Self-citationSolomkin, J., Evans, D., Slepavicius, A., Lee, P., Marsh, A., Tsai, L., Sutcliffe, J. A., & Horn, P. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2016.4237 · Cited by 276
Kinetic interactions of tazobactam with beta-lactamases from all major structural classes
Bush, K., Macalintal, C., Rasmussen, B. A., Lee, V. J., & Yang, Y. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.851 · Cited by 274
First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
Humphries, R. M., Yang, S., Hemarajata, P., Ward, K. W., Hindler, J. A., Miller, S. A., & Gregson, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01165-15 · Cited by 255
The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world
Doi, Y., Iovleva, A., & Bonomo, R. A. (2017) · Journal of Travel Medicine · doi:10.1093/jtm/taw102 · Cited by 248
Self-citationHackel, M. A., Tsuji, M., Yamano, Y., Echols, R., Karlowsky, J. A., & Sahm, D. F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01968-17 · Cited by 235
Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., Kosiek, K., Martinez de Tejada, B., Roux, X., Shiber, S., et al. (2018) · JAMA · doi:10.1001/jama.2018.3627 · Cited by 214
Pogue, J. M., Kaye, K. S., Veve, M. P., Patel, T. S., Gerlach, A. T., Davis, S. L., Puzniak, L. A., File, T. M., Olson, S., Dhar, S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz816 · Cited by 206
Self-citationAkajagbor, D. S., Wilson, S. L., Shere-Wolfe, K. D., Dakum, P., Charurat, M. E., & Gilliam, B. L. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit453 · Cited by 205
Yayan, J., Ghebremedhin, B., & Rasche, K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139836 · Cited by 204
Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene
Ito, R., Mustapha, M. M., Tomich, A. D., Callaghan, J. D., McElheny, C. L., Mettus, R. T., Shanks, R. M. Q., Sluis-Cremer, N., & Doi, Y. (2017) · mBio · doi:10.1128/mbio.00749-17 · Cited by 204
Hackel, M. A., Tsuji, M., Yamano, Y., Echols, R., Karlowsky, J. A., & Sahm, D. F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00093-17 · Cited by 202
Short-Course Nitrofurantoin for the Treatment of Acute Uncomplicated Cystitis in Women
Gupta, K. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.20.2207 · Cited by 192
Polymyxin B: similarities to and differences from colistin (polymyxin E)
Kwa, A., Kasiakou, S. K., Tam, V. H., & Falagas, M. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.5.811 · Cited by 190
Zanetti, G., Bally, F., Greub, G., Garbino, J., Kinge, T., Lew, D., Romand, J.-A., Bille, J., Aymon, D., Stratchounski, L., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3442-3447.2003 · Cited by 190
Neuner, E. A., Sekeres, J., Hall, G. S., & van Duin, D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00402-12 · Cited by 189
Self-citationThe Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections
Tamma, P. D., & Rodriguez-Baňo, J. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix034 · Cited by 186
Self-citationHooton, T. M., Scholes, D., Gupta, K., Stapleton, A. E., Roberts, P. L., & Stamm, W. E. (2005) · JAMA · doi:10.1001/jama.293.8.949 · Cited by 185
Lucasti, C., Vasile, L., Sandesc, D., Venskutonis, D., McLeroth, P., Lala, M., Rizk, M. L., Brown, M. L., Losada, M. C., Pedley, A., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-16 · Cited by 182
Phe, K., Lee, Y., McDaneld, P. M., Prasad, N., Yin, T., Figueroa, D. A., Musick, W. L., Cottreau, J. M., Hu, M., & Tam, V. H. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02476-13 · Cited by 180
Castanheira, M., Farrell, S. E., Krause, K. M., Jones, R. N., & Sader, H. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01896-13 · Cited by 177
Lee, N.-Y., Lee, C.-C., Huang, W.-H., Tsui, K.-C., Hsueh, P.-R., & Ko, W.-C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis916 · Cited by 175
Nelson, K., Hemarajata, P., Sun, D., Rubio-Aparicio, D., Tsivkovski, R., Yang, S., Sebra, R., Kasarskis, A., Nguyen, H., Hanson, B. M., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00989-17 · Cited by 170
Ackley, R., Roshdy, D., Meredith, J., Minor, S., Anderson, W. E., Capraro, G. A., & Polk, C. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02313-19 · Cited by 170
Talbot, G. H., Jezek, A., Murray, B. E., Jones, R. N., Ebright, R. H., Nau, G. J., Rodvold, K. A., Newland, J. G., Boucher, H. W., & The Infectious Diseases Society of America (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz089 · Cited by 168
Sims, M., Mariyanovski, V., McLeroth, P., Akers, W., Lee, Y.-C., Brown, M. L., Du, J., Pedley, A., Kartsonis, N. A., & Paschke, A. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx139 · Cited by 166
Garrec, H., Drieux-Rouzet, L., Golmard, J.-L., Jarlier, V., & Robert, J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02130-10 · Cited by 160
Tamma, P. D., Conley, A. T., Cosgrove, S. E., Harris, A. D., Lautenbach, E., Amoah, J., Avdic, E., Tolomeo, P., Wise, J., Subudhi, S., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.6226 · Cited by 160
Self-citationShaw, E., Rombauts, A., Tubau, F., Padullés, A., Càmara, J., Lozano, T., Cobo-Sacristán, S., Sabe, N., Grau, I., Rigo-Bonnin, R., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx496 · Cited by 159
Tuon, F. F., Rigatto, M. H., Lopes, C. K., Kamei, L. K., Rocha, J. L. L., & Zavascki, A. P. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.12.002 · Cited by 150
Livermore, D. M., Andrews, J. M., Hawkey, P. M., Ho, P., Keness, Y., Doi, Y., Paterson, D. L., & Woodford, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks088 · Cited by 148
Rigatto, M. H., de Oliveira, M. S., Neto, L. V. P., Levin, A. S., Carrilho, C. M. D. D. M., Tanita, M. T., Tuon, F. F., Cardoso, D. E., Lopes, N. T., Falci, D. R., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02634-15 · Cited by 145
Shields, R. K., Nguyen, M. H., Press, E. G., Chen, L., Kreiswirth, B. N., & Clancy, C. J. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx101 · Cited by 130
Self-citationSader, H. S., Castanheira, M., Shortridge, D., Mendes, R. E., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01045-17 · Cited by 120
Barnes, M. D., Taracila, M. A., Rutter, J. D., Bethel, C. R., Galdadas, I., Hujer, A. M., Caselli, E., Prati, F., Dekker, J. P., Papp‐Wallace, K. M., et al. (2018) · mBio · doi:10.1128/mbio.02085-18 · Cited by 119
Self-citationWalkty, A. J., Adam, H. J., Baxter, M. R., Denisuik, A. J., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., & Zhanel, G. G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02744-13 · Cited by 116
Goodlet, K. J., Benhalima, F. Z., & Nailor, M. D. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02165-18 · Cited by 116
Chopra, T., Marchaim, D., Veltman, J., Johnson, P., Zhao, J. J., Tansek, R., Hatahet, D., Chaudhry, K., Pogue, J. M., Hiro, R., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05419-11 · Cited by 115
Papp‐Wallace, K. M., Barnes, M. D., Alsop, J., Taracila, M. A., Bethel, C. R., Becka, S. A., van Duin, D., Kreiswirth, B. N., Kaye, K. S., & Bonomo, R. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00174-18 · Cited by 107
Self-citationShields, R. K., McCreary, E. K., Marini, R. V., Kline, E. G., Jones, C. E., Hao, B., Chen, L., Kreiswirth, B. N., Doi, Y., Clancy, C. J., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1131 · Cited by 106
Self-citationBiagi, M. J., Wu, T., Lee, M., Patel, S., Butler, D. A., & Wenzler, E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01426-19 · Cited by 105
Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity
de Oliveira, M. S., do Prado, G. V. B., Costa, S. F., Grinbaum, R. S., & Levin, A. S. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.07.018 · Cited by 99
Castanheira, M., Davis, A. P., Mendes, R. E., Serio, A. W., Krause, K. M., & Flamm, R. K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00313-18 · Cited by 92
Robberts, F. J. L., Kohner, P. C., & Patel, R. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01687-08 · Cited by 89
Fraile-Ribot, P. A., Zamorano, L., Orellana, R., del Barrio-Tofiño, E., Sánchez-Diener, I., Cortés-Lara, S., López-Causapé, C., Cabot, G., Bou, G., Martı́nez-Martı́nez, L., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02165-19 · Cited by 87
Eckmann, C., Montravers, P., Bassetti, M., Bodmann, K. ‐., Heizmann, W. R., García, M. S., Guirao, X., Capparella, M. R., Simoneau, D., & Dupont, H. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt142 · Cited by 84
Punjabi, C. D., Tien, V., Meng, L., Deresinski, S. C., & Holubar, M. K. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz364 · Cited by 83
Burgess, D. S., & Hall, R. G. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2003.11.007 · Cited by 80
Senchyna, F., Gaur, R. L., Sandlund, J., Truong, C., Tremintin, G., Kültz, D., Gómez, C. A., Tamburini, F. B., Andermann, T. M., Bhatt, A. S., et al. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.10.004 · Cited by 78
Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam Resistance
Tamma, P. D., Beisken, S., Bergman, Y., Posch, A. E., Avdic, E., Sharara, S. L., Cosgrove, S. E., & Simner, P. J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1306 · Cited by 72
Self-citationWang, R., Cosgrove, S. E., Tschudin‐Sutter, S., Han, J., Turnbull, A. E., Hsu, A. J., Avdic, E., Carroll, K. C., & Tamma, P. D. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw132 · Cited by 70
Self-citationAitken, S. L., Tarrand, J. J., Deshpande, L. M., Tverdek, F. P., Jones, A. L., Shelburne, S. A., Prince, R. A., Bhatti, M. M., Rolston, K. V. I., Jones, R. N., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw398 · Cited by 68
Self-citationClancy, C. J., Potoski, B. A., Buehrle, D. J., & Nguyen, M. H. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz344 · Cited by 67
Self-citationCastanheira, M., Doyle, T. B., Kantro, V., Mendes, R. E., & Shortridge, D. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01951-19 · Cited by 65
Hobson, C. A., Bonacorsi, S., Fahd, M., Baruchel, A., Cointe, A., Poey, N., Jacquier, H., Doit, C., Monjault, A., Tenaillon, O., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02463-18 · Cited by 64
Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline
Falagas, M. E., Karageorgopoulos, D. E., & Dimοpoulos, G. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048356 · Cited by 62
Castanheira, M., Duncan, L. R., Mendes, R. E., Sader, H. S., & Shortridge, D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02125-17 · Cited by 61
Tamma, P. D., Sharara, S. L., Pana, Z. D., Amoah, J., Fisher, S. L., Tekle, T., Doi, Y., & Simner, P. J. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz353 · Cited by 60
Self-citationSorlí, L., Luque, S., Li, J., Campillo, N., Danés-Castells, M., Montero, M., Segura, C., Grau, S., & Horcajada, J. P. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.06.011 · Cited by 55
Zhou, M., Wang, Y., Liu, C., Kudinha, T., Liu, X., Luo, Y., Yang, Q., Sun, H., Hu, J., & Xu, Y. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s166790 · Cited by 52
Canver, M. C., Satlin, M. J., Westblade, L. F., Kreiswirth, B. N., Chen, L., Robertson, A., Fauntleroy, K. A., Spina, M. L., Callan, K., & Jenkins, S. G. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00672-19 · Cited by 50
Benchetrit, L., Mathy, V., Armand-Lefèvre, L., Bouadma, L., & Timsit, J. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.10.023 · Cited by 50
Elliott, Z. S., Barry, K. E., Cox, H. L., Stoesser, N. E., Carroll, J., Vegesana, K. B., Kotay, S. M., Sheppard, A. E., Wailan, A. M., Crook, D. W., et al. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00634-19 · Cited by 49
Self-citationGolden, A., Adam, H. J., Baxter, M. R., Walkty, A. J., Lagacé-Wiens, P. R. S., Karlowsky, J. A., & Zhanel, G. G. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115012 · Cited by 49
Carvalhaes, C. G., Castanheira, M., Sader, H. S., Flamm, R. K., & Shortridge, D. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.11.021 · Cited by 47
Recognizing and Overcoming Resistance to New Beta-Lactam/Beta-Lactamase Inhibitor Combinations
Ho, S., Nguyen, L., Trinh, T. D., & MacDougall, C. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0690-9 · Cited by 37
Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study
Strich, J. R., Warner, S., Lai, Y. L., Demirkale, C. Y., Powers, J. H., Danner, R. L., & Kadri, S. S. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30153-5 · Cited by 37
Sutherland, C. A., Verastegui, J. E., & Nicolau, D. P. (2016) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-016-0155-z · Cited by 30
Sieswerda, E., van den Brand, M., van den Berg, R. B., Sträter, J., Schouls, L. M., van Dijk, K., & Budding, A. E. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz495 · Cited by 30
Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia
Paterson, D. L., Henderson, A., & Harris, P. N. A. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000623 · Cited by 30
Satlin, M. J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa065 · Cited by 23
Kulengowski, B., & Burgess, D. S. (2019) · Pathogens and Disease · doi:10.1093/femspd/ftz040 · Cited by 21
Sears, C. L., File, T. M., Alexander, B. D., McQuillen, D. P., MacIntyre, A. T., Allen, U., Colasanti, J. A., Siddiqui, J., Reveles, K. R., Busky, C., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1040 · Cited by 16
Cited by
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
Castanheira, M., Simner, P. J., & Bradford, P. A. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab092 · Cited by 796
Ma, J., Song, X., Li, M., Yu, Z., Cheng, W., Yu, Z., Zhang, W., Zhang, Y., Shen, A., Sun, H., et al. (2023) · Microbiological Research · doi:10.1016/j.micres.2022.127249 · Cited by 308
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
Kunz Coyne, A. J., El Ghali, A., Holger, D., Rebold, N., & Rybak, M. J. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-022-00591-2 · Cited by 275
Mezcord, V., Escalante, J., Nishimura, B., Traglia, G. M., Sharma, R., Valle, Q., Tuttobene, M. R., Subils, T., Marin, I., Pasterán, F., et al. (2023) · doi:10.20944/preprints202306.0950.v1 · Cited by 27
Self-citationLiao, J. X., Appaneal, H. J., Menon, A., Lopes, V., LaPlante, K. L., & Caffrey, A. R. (2023) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00827-9 · Cited by 16
Metadata
- Authors
- Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-04-01
- Volume
- 72
- Issue
- 7
- Pages
- 1109-1116
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W3094338265
- Cited by
- 390
- References
- 104
- FWCI
- 22.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.